Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial.
De Wolf K, Rottey S, Vermaelen K, Decaestecker K, Sundahl N, De Lobel L, Goetghebeur E, De Meerleer G, Lumen N, Fonteyne V, De Maeseneer D, Ost P. De Wolf K, et al. Among authors: de maeseneer d, de lobel l, de meerleer g. Radiat Oncol. 2017 Sep 22;12(1):157. doi: 10.1186/s13014-017-0893-x. Radiat Oncol. 2017. PMID: 28938918 Free PMC article. Clinical Trial.
A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic response.
Sundahl N, De Wolf K, Rottey S, Decaestecker K, De Maeseneer D, Meireson A, Goetghebeur E, Fonteyne V, Verbeke S, De Visschere P, Reynders D, Van Gele M, Brochez L, Ost P. Sundahl N, et al. Among authors: de maeseneer d, de wolf k, de visschere p. J Transl Med. 2017 Jun 29;15(1):150. doi: 10.1186/s12967-017-1251-3. J Transl Med. 2017. PMID: 28662677 Free PMC article. Clinical Trial.
Pembrolizumab for the treatment of bladder cancer.
Sundahl N, Rottey S, De Maeseneer D, Ost P. Sundahl N, et al. Among authors: de maeseneer d. Expert Rev Anticancer Ther. 2018 Feb;18(2):107-114. doi: 10.1080/14737140.2018.1421461. Epub 2017 Dec 29. Expert Rev Anticancer Ther. 2018. PMID: 29284318 Review.
Evaluating the Current Place of Radiotherapy as Treatment Option for Patients With Muscle Invasive Bladder Cancer in Belgium.
Fonteyne V, Rammant E, Ost P, Lievens Y, De Troyer B, Rottey S, De Meerleer G, De Maeseneer D, De Ridder D, Decaestecker K. Fonteyne V, et al. Among authors: de ridder d, de maeseneer d, de meerleer g, de troyer b. Clin Genitourin Cancer. 2018 Dec;16(6):e1159-e1169. doi: 10.1016/j.clgc.2018.07.026. Epub 2018 Aug 11. Clin Genitourin Cancer. 2018. PMID: 30190222
Randomized Phase 1 Trial of Pembrolizumab with Sequential Versus Concomitant Stereotactic Body Radiotherapy in Metastatic Urothelial Carcinoma.
Sundahl N, Vandekerkhove G, Decaestecker K, Meireson A, De Visschere P, Fonteyne V, De Maeseneer D, Reynders D, Goetghebeur E, Van Dorpe J, Verbeke S, Annala M, Brochez L, Van der Eecken K, Wyatt AW, Rottey S, Ost P. Sundahl N, et al. Among authors: de maeseneer d. Eur Urol. 2019 May;75(5):707-711. doi: 10.1016/j.eururo.2019.01.009. Epub 2019 Jan 19. Eur Urol. 2019. PMID: 30665814 Clinical Trial.
Targeting FGFR in bladder cancer: ready for clinical practice?
De Keukeleire S, De Maeseneer D, Jacobs C, Rottey S. De Keukeleire S, et al. Among authors: de maeseneer d. Acta Clin Belg. 2020 Feb;75(1):49-56. doi: 10.1080/17843286.2019.1685738. Epub 2019 Oct 31. Acta Clin Belg. 2020. PMID: 31671027 Review.
Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS): study protocol for a phase 2, open-label, randomized controlled trial.
Spaas M, Sundahl N, Hulstaert E, Kruse V, Rottey S, De Maeseneer D, Surmont V, Meireson A, Brochez L, Reynders D, Goetghebeur E, Van den Begin R, Van Gestel D, Renard V, Dirix P, Mestdagh P, Ost P. Spaas M, et al. Among authors: de maeseneer d. BMC Cancer. 2021 May 7;21(1):514. doi: 10.1186/s12885-021-08088-w. BMC Cancer. 2021. PMID: 33962592 Free PMC article.
Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial.
Verghote F, Poppe L, Verbeke S, Dirix P, Albersen M, De Meerleer G, Berghen C, Ost P, Villeirs G, De Visschere P, De Man K, De Maeseneer D, Rottey S, Van Praet C, Decaestecker K, Fonteyne V. Verghote F, et al. Among authors: de maeseneer d. BMC Cancer. 2021 Oct 18;21(1):1113. doi: 10.1186/s12885-021-08861-x. BMC Cancer. 2021. PMID: 34663254 Free PMC article. Clinical Trial.
21 results